Frontiers in Pharmacology | Pharmacoepidemiology

Original Research

Published on 05 Mar 2025

Non-chemotherapy drugs inducing agranulocytosis: a disproportionality analysis based on the FAERS database

in Pharmacoepidemiology

Shanshan Wu
Lina Huang
Jiajia Chen
Xiaochun Xie
Shaokai Huang
Xiaojie Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1525307

692 views

Original Research

Accepted on 26 Feb 2025

ENHANCING MEDICATION APPROPRIATENESS: INSIGHTS FROM THE STOPP (SCREENING TOOL OF OLDER PERSONS PRESCRIPTIONS) CRITERIA VERSION 3 ON ELDERLY PRESCRIBING PRACTICES IN PAKISTAN AUTHORS

in Pharmacoepidemiology

Halima Sadia
Safila Naveed
Hina Rehman
SHAZIA QASIM JAMSHED
Huma Dilshad

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1551819

Original Research

Published on 19 Feb 2025

Impact of levetiracetam on direct oral anticoagulant level and outcomes among older Asian patients with atrial fibrillation

in Pharmacoepidemiology

Yu-Ting Huang
Tzu-Ling Chen
Yun-Lin Huang
Ching-Hua Kuo
Yu-Fong Peng
Sung-Chun Tang
Jiann-Shing Jeng
Chih-Feng Huang
Shin-Yi Lin
Fang-Ju Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1505665

929 views

Original Research

Published on 18 Feb 2025

Pharmacovigilance analysis of polatuzumab plus bendamustine and rituximab treatment protocol: identifying comprehensive safety signals using FDA database

in Pharmacoepidemiology

Fang Wu
Siliang Wang
Xihui Xu
Weihui Zhang
Jie Zhou
Runyan Niu
Wenting Cai
Yonggong Yang
Mengying Liu
Jinping Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1459067

958 views

Original Research

Published on 17 Feb 2025

Association between GLP-1 RAs and DPP-4 inhibitors with biliary disorders: pharmacovigilance analysis

in Pharmacoepidemiology

Long He
Jinwei Li
Xiong Cheng
Li Luo
Yilan Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1509561

1,464 views

Original Research

Published on 13 Feb 2025

Real-world pharmacovigilance investigation of imipenem/cilastatin: signal detection using the FDA Adverse Event Reporting System (FAERS) database

in Pharmacoepidemiology

Peng Jia
Yusen Zhou
Yuan Gao
Shangyu Wang
Jiangliu Yin
Yixiang Lian
Quanyou Lai

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1524159

1,020 views

Original Research

Published on 13 Feb 2025

Mining and analysis of dizziness adverse event signals in postoperative analgesia patients based on the FDA adverse event reporting system database

in Pharmacoepidemiology

Fengqi Zhou
Haiou He
Zhen Zhang
Jing Gao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1488469

747 views

Original Research

Published on 11 Feb 2025

Disproportionality analysis of upadacitinib-related adverse events in inflammatory bowel disease using the FDA adverse event reporting system

in Pharmacoepidemiology

Shiyi Wang
Xiaojian Wang
Jing Ding
Xudong Zhang
Hongmei Zhu
Yihong Fan
Changbo Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1436183

1,389 views

Correction

Published on 07 Feb 2025

Corrigendum: Adverse drug events (ADEs) risk signal mining related to eculizumab based on the FARES database

in Pharmacoepidemiology

Xi-Feng Wang
Lu-Ri Bao
Ta-La Hu
Rui-Feng Xu
Wu-Niri Gao
Jing-Yuan Wang
Jian-Rong Zhao
Zhen-Li Fu
Shu-Fang Wang
Yan Meng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1558930

687 views

Systematic Review

Accepted on 05 Feb 2025

Is tranexamic acid effective for all traumatic brain injury patients? A Severity Based Systematic Review and Meta-Analysis

in Pharmacoepidemiology

Wentao Bian
Wenkai Bian
Yixuan Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1472232

104 views

Original Research

Published on 29 Jan 2025

Exploring the association between herbal medicine usage and drug-induced liver injury: insights from a nationwide population-based cohort study using SCCS in South Korea

in Pharmacoepidemiology

Taehyun Yang
Juhee Ahn
Sungho Won
Sanghun Lee

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1498124

3,443 views

Original Research

Published on 24 Jan 2025

Data mining and safety analysis of voriconazole in patients with a hematological malignant tumor based on the FAERS database: differences between children and adults

in Pharmacoepidemiology

Hao Li
Manxue Jiang
Xiaona Pan
Lingti Kong

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1524702

1,023 views

Original Research

Published on 23 Jan 2025

A post-marketing pharmacovigilance study of triazole antifungals: adverse event data mining and analysis based on the FDA adverse event reporting system database

in Pharmacoepidemiology

Yalan Tian
Min Jin
Hong Ning

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1462510

1,150 views

Systematic Review

Published on 23 Jan 2025

Global bibliometric analysis of traditional Chinese medicine regulating gut microbiota in the treatment of diabetes from 2004 to 2024

in Pharmacoepidemiology

Jieling Liang
Xiaojuan Lin
Xin Liao
Xi Chen
Ying Zhou
Lin Zhang
Yunyun Qin
Haoru Meng
Zhongwen Feng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1533984

1,239 views

Original Research

Published on 10 Jan 2025

Overweight and glucose/lipid metabolism abnormality associated with SSRIs: a pharmacovigilance study based on the FDA adverse event reporting system

in Pharmacoepidemiology

Jinming Cao
Zhicong Chen
Yan Wang
Yunpeng Ma
Zhen Yang
Jian Cai
Zhijun Xiao
Feng Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1517546

1,493 views

Editorial

Published on 10 Jan 2025

Editorial: Biologic drugs in immune-mediated inflammatory diseases, validation, drug-utilization, effectiveness, regulation, costs, and safety in the real-world

in Pharmacoepidemiology

Irma Convertino
Luciane Cruz Lopes
Nicole Pratt
Ylenia Ingrasciotta
Marco Tuccori

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1542453

582 views